Using Genetics To Dissect SARS-CoV-2 Infection

To uncover the key cellular pathways associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infectivity, Daniloski and coworkers used CRISPR-based whole-genome screening. Their results could propose new or repositioned drugs for the ongoing fight against COVID-19.

Detalles Bibliográficos
Autores principales: Brest, Patrick, Mograbi, Baharia, Hofman, Paul, Milano, Gerard
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Spotlight
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689311/
https://www.ncbi.nlm.nih.gov/pubmed/33309104
http://dx.doi.org/10.1016/j.tig.2020.11.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689311/
https://www.ncbi.nlm.nih.gov/pubmed/33309104
http://dx.doi.org/10.1016/j.tig.2020.11.007

Ejemplares similares